Molecule Details
InChIKeyLQVXSNNAFNGRAH-QHCPKHFHSA-N
Compound NameBms-754807
Canonical SMILESC[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)33
Pfam Stratification Cross-Family
Avg pChEMBL6.99
SourceBindingDB;ChEMBL;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB15399
Drug NameBMS-754807
CAS Number1001350-96-4
Groups investigational
ATC Codes nan
DescriptionBMS-754807 is under investigation in clinical trial NCT00908024 (Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors).

Cross-references: BindingDB: 107000 ChEBI: 88339 CHEMBL575448 ChemSpider: 24637163 PDB: EBI ZINC: ZINC000043203317
Target Activities (33)
Target Gene Organism Category Pfam pChEMBL Type Source
P06213 INSR Homo sapiens Human PF00757 PF17870 PF07714 PF01030 8.8 IC50 ChEMBL;BindingDB
P06729 CD2 Homo sapiens Human PF05790 PF07686 8.7 pIC50 TTD_MultiTarget
P24941 CDK2 Homo sapiens Human PF00069 8.7 pIC50 TTD_MultiTarget
P08069 IGF1R Homo sapiens Human PF00757 PF07714 PF01030 8.7 IC50 ChEMBL;BindingDB
Q16620 NTRK2 Homo sapiens Human PF07679 PF13855 PF16920 PF01462 PF07714 8.4 IC50 ChEMBL;BindingDB
P04629 NTRK1 Homo sapiens Human PF13855 PF16920 PF07714 PF18613 8.1 IC50 ChEMBL;BindingDB
Q05397 PTK2 Homo sapiens Human PF21477 PF00373 PF18038 PF03623 PF07714 8.0 Kd ChEMBL
P08581 MET Homo sapiens Human PF07714 PF01437 PF01403 PF01833 7.8 IC50 ChEMBL
O14965 AURKA Homo sapiens Human PF00069 7.5 Kd ChEMBL
Q04912 MST1R Homo sapiens Human PF07714 PF01437 PF01403 PF01833 7.4 IC50 ChEMBL
P14616 INSRR Homo sapiens Human PF00041 PF00757 PF07714 PF01030 7.3 Kd ChEMBL
Q96GD4 AURKB Homo sapiens Human PF00069 7.2 IC50 ChEMBL
O00444 PLK4 Homo sapiens Human PF00069 PF18190 PF18409 7.1 Kd ChEMBL
Q13470 TNK1 Homo sapiens Human PF07714 PF22931 6.8 Kd ChEMBL
P36888 FLT3 Homo sapiens Human PF00047 PF07714 6.8 IC50 ChEMBL
Q14289 PTK2B Homo sapiens Human PF21477 PF00373 PF18038 PF03623 PF07714 6.8 Kd ChEMBL
Q16288 NTRK3 Homo sapiens Human PF07679 PF00047 PF13855 PF16920 PF01462 PF07714 6.7 Kd ChEMBL
Q9HC98 NEK6 Homo sapiens Human PF00069 6.7 Kd ChEMBL
Q9UGJ0 PRKAG2 Homo sapiens Human PF00571 6.6 Kd ChEMBL
O60674 JAK2 Homo sapiens Human PF18379 PF18377 PF17887 PF07714 PF21990 6.5 IC50 ChEMBL
Q02763 TEK Homo sapiens Human PF00041 PF10430 PF07714 6.5 Kd ChEMBL
P54619 PRKAG1 Homo sapiens Human PF00571 6.4 Kd ChEMBL
P29317 EPHA2 Homo sapiens Human PF14575 PF25599 PF01404 PF00041 PF07714 PF00536 6.3 Kd BindingDB
P35590 TIE1 Homo sapiens Human PF00041 PF00047 PF07714 6.2 Kd ChEMBL
Q8TDX7 NEK7 Homo sapiens Human PF00069 6.2 Kd ChEMBL
Q8TD19 NEK9 Homo sapiens Human PF00069 PF25390 6.2 Kd ChEMBL
P07949 RET Homo sapiens Human PF00028 PF07714 PF17756 PF17812 PF17813 PF22540 6.2 Kd ChEMBL
P49841 GSK3B Homo sapiens Human PF00069 6.1 IC50 ChEMBL
P16591 FER Homo sapiens Human PF00611 PF07714 PF00017 6.1 Kd ChEMBL
P24864 CCNE1 Homo sapiens Human PF02984 PF00134 6.1 IC50 ChEMBL
Q08345 DDR1 Homo sapiens Human PF21114 PF00754 PF07714 6.1 Kd ChEMBL
Q13131 PRKAA1 Homo sapiens Human PF16579 PF21147 PF00069 6.1 Kd ChEMBL
P49137 MAPKAPK2 Homo sapiens Human PF00069 6.0 IC50 ChEMBL
DrugBank Target Actions (3)
Target Gene Target Name Action Type
P06213 INSR Insulin receptor inhibitor targets
P08069 IGF1R Insulin-like growth factor 1 receptor inhibitor targets
P31749 AKT1 RAC-alpha serine/threonine-protein kinase inhibitor targets